Low GPR81 in ER+ breast cancer cells drives tamoxifen resistance through inducing PPARα-mediated fatty acid oxidation
- 31 May 2024
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 350, 122763
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (31770968, 31800661)
This publication has 53 references indexed in Scilit:
- Fatty acid oxidation protects cancer cells from apoptosis by increasing mitochondrial membrane lipidsCell Reports, 2022
- The lactate receptor GPR81 mediates hepatic lipid metabolism and the therapeutic effect of metformin on experimental NAFLDsEuropean Journal of Pharmacology, 2022
- The roles of GRP81 as a metabolic sensor and inflammatory mediatorJournal of Cellular Physiology, 2020
- Autophagy and Lipid Metabolism2019
- Role of PPAR receptor in different diseases and their ligands: Physiological importance and clinical implicationsEuropean Journal of Medicinal Chemistry, 2019
- JAK/STAT3-Regulated Fatty Acid β-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and ChemoresistanceCell Metabolism, 2018
- Regulation, Signaling, and Physiological Functions of G-ProteinsJournal of Molecular Biology, 2016
- Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver diseaseJournal of Hepatology, 2015
- An Autocrine Lactate Loop Mediates Insulin-Dependent Inhibition of Lipolysis through GPR81Cell Metabolism, 2010
- An Overview on GPCRs and Drug Discovery: Structure-Based Drug Design and Structural Biology on GPCRs2009